CVA Family Office’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-425
| Closed | -$3.75K | – | 1013 |
|
|
2023
Q1 | $3.75K | Hold |
425
| – | – | ﹤0.01% | 806 |
|
|
2022
Q4 | $3.25K | Hold |
425
| – | – | ﹤0.01% | 782 |
|
|
2022
Q3 | $3K | Hold |
425
| – | – | ﹤0.01% | 763 |
|
|
2022
Q2 | $3K | Buy |
425
+275
| +183% | +$1.94K | ﹤0.01% | 782 |
|
|
2022
Q1 | $2K | Sell |
150
-40
| -21% | -$533 | ﹤0.01% | 858 |
|
|
2021
Q4 | $5K | Buy |
+190
| New | +$5K | ﹤0.01% | 737 |
|
|
2021
Q3 | – | Sell |
-40
| Closed | -$2K | – | 363 |
|
|
2021
Q2 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 861 |
|